Dr. Dimanthi Pliatsika

ZHAW Life Sciences und Facility Management
Fachgruppe Organische Chemie und Medizinalchemie
Einsiedlerstrasse 31
8820 Wädenswil

Netzwerk

Rimle, L., Pliatsika, D., Arnold, N., Kurth, S., Kaiser, M., Mäser, P., Kemmler, M., Adams, M., Riedl, R., & von Ballmoos, C. (2025). Dissecting structural requirements of leucinostatin A derivatives for antiprotozoal activity and mammalian toxicity. Journal of Medicinal Chemistry, 68(4), 4237–4258. https://doi.org/10.1021/acs.jmedchem.4c01989
Pliatsika, D., Blatter, C., & Riedl, R. (2024). Targeted protein degradation : current molecular targets, localization, and strategies. Drug Discovery Today, 29(11), 104178. https://doi.org/10.1016/j.drudis.2024.104178
Kalbermatter, D., Jeckelmann, J.-M., Wyss, M., Shrestha, N., Pliatsika, D., Riedl, R., Lemmin, T., Plattet, P., & Fotiadis, D. (2023). Structure and supramolecular organization of the canine distemper virus attachment glycoprotein. Proceedings of the National Academy of Sciences of the United States of America, 120(6), e2208866120. https://doi.org/10.1073/pnas.2208866120
Zizzari, A. T., Pliatsika, D., Gall, F., Fischer, T., & Riedl, R. (2021). New perspectives in oral peptide delivery. Drug Discovery Today, 26(4), 1097–1105. https://doi.org/10.1016/j.drudis.2021.01.020

Rimle, L., Pliatsika, D., Arnold, N., Kurth, S., Kaiser, M., Mäser, P., Kemmler, M., Adams, M., Riedl, R., & von Ballmoos, C. (2024). Molecular basis for leucinostatin A toxicity in mammals [Conference presentation]. Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1865(149316). https://doi.org/10.1016/j.bbabio.2024.149316